Par Pharmaceutical (PRX) Tops Q2 EPS by 7c
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Revenue Growth %: +31.3%
Financial Fact:
Selling, general and administrative: 42.16M
Today's EPS Names:
SNPS, SPTN, GAME, More
Revenue Growth %: +31.3%
Financial Fact:
Selling, general and administrative: 42.16M
Today's EPS Names:
SNPS, SPTN, GAME, More
Trade PRX Now!
Par Pharmaceutical (NYSE: PRX) reported Q2 EPS of $0.84, $0.07 better than the analyst estimate of $0.77. Revenue for the quarter came in at $224.2 million versus the consensus estimate of $216.47 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- China TechFaith (CNTF) Swings to Q1 Profitl; Guides Q2 Sales
- Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q1 EPS; Guides Q2 EPS, Comps
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
